Canada: With Quantum Of Damages Settled, Parties Unable To Agree On Quantum Of Costs Or Calculation of Pre- and Post-Judgment Interest in Section 8 Case (Intellectual Property Weekly Abstracts Bulletin – Week Of August 11, 2014)

Last Updated: August 15 2014

Edited by Chantal Saunders and Beverley Moore , Adrian Howard and Ryan Steeves

NOC Cases

With Quantum of Damages Settled, Parties Unable to Agree on Quantum of Costs or Calculation of Pre- and Post-Judgment Interest in Section 8 Case
Teva Canada Ltd. v. Pfizer Canada Inc., 2014 FC 634

Drug: venlafaxine

In the Federal Court's earlier decision (summary here), the parties were instructed to attempt to reach an agreement on the quantity of damages and costs in an action for damages under section 8 of the PM(NOC) Regulations. These supplementary reasons report that the parties agreed on the damages accrued during the relevant period (approximately $92 million), but were unable to agree on the quantum of costs, on the calculation of prejudgment interest, or on the rate of post-judgment interest.

Teva was the successful party and was judged entitled to its costs. It claimed costs of approximately $2 million, but in an attempt to bring the matter to a close, requested a lump-sum award of $1.8 million. Alternatively, Teva requested its costs be determined at the upper level of Column IV, and include various other costs and expenses for attendance at discoveries, motions, witness meetings, travel and expert/fact witness fees. Considering various objections made by Pfizer, the Court determined that this was not an appropriate case for the Court to award a lump-sum; the Court ordered the costs to be assessed, guided by the decisions in Janssen-Ortho Inc. v. Novopharm Ltd.  and Apotex Inc. v. H Lundbeck A/S. Notably, the Court directed that Teva was to be entitled to its costs at the upper level of Column IV, among other things.

With respect to prejudgment interest, the date from which the prejudgment interest ran was determined in the Court's earlier decision; the issue here was on what sum is the interest calculated. The Court held that prejudgment interest on the damage award is calculated as follows: "First, the interest owed from the beginning of the Relevant Period to the end must be calculated from the beginning of each month on the basis of the damages accruing that month and second, the interest on the total amount of the award outstanding at the end of the Relevant Period must be calculated from the end of the Relevant Period to the date of judgment."

With respect to post-judgment interest, it was accepted that it accrues on the money owed including costs and pre-judgment interest, from the date of the final judgment at the post-judgment interest rate. The Court held that section 127(1) of the Courts of Justice Act governs post-judgment interest in this case, which was determined to be 3% at the time.
Teva was awarded approximately $32 million in prejudgment interest, 3% post-judgment interest on approximately $124 million (the sum of damages and pre-judgment interest), and its assessed costs, which are to be awarded at the rate of 3% from the date of judgment until payment.


Causes of action found against Pfizer for a BC class-action certification based on the VIAGRA® patent
Low v. Pfizer Canada Inc., 2014 BCSC 1469

Pfizer had a Canadian patent for VIAGRA® that was found to not comply with the disclosure requirement by the Supreme Court in an earlier PM(NOC) proceeding (Teva Canada Ltd. v. Pfizer Canada Inc., 2012 SCC 60).  This finding was later applied on summary judgment in favour of Apotex (Apotex v. Pfizer Ireland Pharmaceuticals, 2012 FC 1339) and upheld on appeal (Pfizer Ireland Pharmaceuticals v. Apotex Inc., 2014 FCA 13).  

The plaintiff in this proceeding now seeks to certify a class action against Pfizer. The plaintiffs allege that Pfizer wrongfully obtained and relied on a patent, which inflated the price of VIAGRA® by delaying the introduction of competing generic versions.
The only issue on this application was whether the plaintiff's claim discloses a cause of action for the purposes of certification.  The three causes of action pleaded were:

  1. unlawful interference with economic relations;
  2. waiver of tort; and
  3. unjust enrichment.

The Court found that subsection 55.2(4) of the Patent Act and the PM(NOC) Regulations do not govern the rights of actions of consumers.  So it was held that while the statutes do not create a right of action for consumers, neither do they bar an action by consumers if the conduct that was in breach of statute is also relevant to a common law cause of action.  

In the result, the Court found a cause of action for the claims to unlawful interference with economic relations and for unjust enrichment.  The other s.4(1) requirements for certification still need to be addressed in a further application.

Industry News

The BLG Life Sciences Group has published LIFESIGNS: Life Sciences Legal Trends in Canada, a Report on Intellectual Property, Litigation, Corporate Commercial legal trends and industry developments in Canada.

About BLG

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions